SynthesisNeurocritical care2022

Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage.

Adnan I Qureshi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.